Biocon Biologics announces top leadership appointments

Posted on:
Key Points

Biocon Biologics Ltd on Friday announced key leadership appointments, including those of Rhonda Duffy as Chief Operating Officer (COO) and Sandeep Athalye as Chief Development Officer...

The company, a subsidiary of Biocon Ltd also announced the appointment of David Gibson as its Global Head - Business Development to lead all licensing, strategic partnering and business development activities..

On the other hand, Athalye, who has been with Biocon Biologics for over six years as its Chief Medical Officer, has been elevated to Chief Development Officer to head CMC, clinical development and medical and regulatory affairs, it added...

"These new additions to the leadership team bring rich, global experience which will help prepare the organisation for the future and ensure a seamless integration of the recently acquired global biosimilars business from Viatris," Biocon Biologics CEO & Managing Director Shreehas Tambe said...

You might be interested in

Top Emerging Business Leader to watch in 2024

12, Jan, 24

India Business News: Join us as we list down some of the top emerging business leaders to watch out in 2024 and get some inspiration from their journey.

Biocon Biologics integrates Vitaris’ biosimilars business

19, Dec, 23

The firm had acquired the American pharmaceutical company’s biosimilars business in November 2022.